MedImmune Parcels Out an Investgational Blood Cancer Candidate

Last week MedImmune Ltd., the biotech arm of AstraZeneca plc (NYSE: AZN), announced two placements for its investigational compound, MEDI4736. The first announcement was with Juno Therapeutics Inc. (NASDAQ: JUNO), which signed an non-exclusive agreement to test its own investigational CD19-directed chimeric antigen receptor (CAR) T cell candidates with MedImmune’s programmed cell death ligand 1 […]

NorthStar Retires $640 Million to 15 CCRCs

Fountains Senior Living Holdings LLC is selling 15 continuing care retirement communities (CCRCs) in 11 states. NorthStar Healthcare Income, Inc., a public, non-traded REIT, has plunked down $640 million for the portfolio, which consists of six entrance-fee and nine rental CCRCs, total 3,637 units. Watermark Retirement Communities will continue as the day-to-day operator of the CCRCs. […]

UCHealth Invests in 12 Colorado Urgent Care Centers

Adeptus Health, the largest and oldest network of freestanding emergency room facilities in the country, is selling a majority stake in all 12 of its Colorado facilities, and two more under construction. The buyer, University of Colorado Health System, plans to rebrand them as UCHealth ER. Adeptus operates more than 60 ERs in affluent areas […]

Ventas Buys Hospitals and Spins off SNFs

Ventas, Inc. (NYSE: VTR) had a busy week, as it paid $1.75 billion for Ardent Health Services, one of the 10 largest for-profit hospitals companies in the United States, from Welsh, Carson, Anderson & Stowe. The plan is to separate Ardent’s hospital operations from its owned real estate and sell the operations to one or […]

Hospital Mergers Heat Up in April

Last week brought word that Boston Medical Center and Tufts Medical Center were moving ahead with merger talks and expect to have a deal by the end of this year. The parties announced they were exploring a merger last December. That news came two days after Massachusetts Attorney General Maura Healey and House Majority Leader […]

Optum Buys MedExpress

UnitedHealth Group (NYSE: UNH) is still in acquisition mode. Two weeks ago its OptumRx subsidiary announced a $1.0 billion deal for pharmacy benefits manager Catamaran Corp. (NASDAQ: CTRX). Last week, another subsidiary, Optum, reached a deal for MedExpress, a privately held chain of full-service neighborhood medical centers in 11 states. Financial terms were not disclosed, […]